Figshareopen access

Supplemental Material for: Drug persistence and treatment outcomes after switching from intravenous to subcutaneous vedolizumab in inflammatory bowel disease

Name: Supplemental Material for: Drug persistence and treatment outcomes after switching from intravenous to subcutaneous vedolizumab in inflammatory bowel disease
License: Open Access

figshare admin karger (2628495) et al.

Figshare · Datasets · License: Open Access

Open Source ↗

medicine, medicine

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1052888
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.